Uromodulin (UMOD) (C-Term) Peptide
UMOD
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all Uromodulin (UMOD) products
- Uromodulin (UMOD)
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- PTCSGTRFRS GSVIDQSRVL NLGPITRKGV QATVSRAFSS LGLLKVWLPL
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-UMOD Antibody(ARP41437_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
Uromodulin (UMOD) peptide (Ovalbumin)
UMOD Reactivity: Human Host: Synthetic WB, Imm, SDS
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Uromodulin (UMOD)
- Synonyms
- ADMCKD2 Peptide, FJHN Peptide, HNFJ Peptide, HNFJ1 Peptide, MCKD2 Peptide, THGP Peptide, THP Peptide, urehr4 Peptide, uromodulin Peptide, UMOD Peptide, Umod Peptide
- Background
-
This gene encodes uromodulin, the most abundant protein in normal urine. Its excretion in urine follows proteolytic cleavage of the ectodomain of its glycosyl phosphatidylinosital-anchored counterpart that is situated on the luminal cell surface of the loop of Henle. Uromodulin may act as a constitutive inhibitor of calcium crystallization in renal fluids. Excretion of uromodulin in urine may provide defense against urinary tract infections caused by uropathogenic bacteria. Defects in this gene are associated with the autosomal dominant renal disorders medullary cystic kidney disease-2 (MCKD2) and familial juvenile hyperuricemic nephropathy (FJHN). These disorders are characterized by juvenile onset of hyperuricemia, gout, and progressive renal failure. While several transcript variants may exist for this gene, the full-length natures of only two have been described to date. These two represent the major variants of this gene and encode the same isoform.
Alias Symbols: ADMCKD2, FJHN, HNFJ, HNFJ1, MCKD2, THGP, THP
Protein Interaction Partner: LTA,MMP8,LTA
Protein Size: 640 - Molecular Weight
- 67 kDa
- Gene ID
- 7369
- NCBI Accession
- NM_001008389, NP_001008390
- UniProt
- P07911
-
You are here:
